Endometrial Cancer Clinical Trials in Wuhan, Hubei
7 recruitingWuhan, Hubei, China
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Merck Sharp & Dohme LLC1,123 enrolled232 locationsNCT06952504
Recruiting
Phase 3
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Endometrial Cancer
BioNTech SE480 enrolled80 locationsNCT06340568
Recruiting
Phase 1
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Cervical CancerEndometrial CancerGynecologic Malignancies
Tongji Hospital97 enrolled1 locationNCT06552598
Recruiting
Cohort Study of Intrauterine Diseases
Endometrial CancerEndometrial HyperplasiaEndometrial Polyps
Wenwen Wang2,000 enrolled1 locationNCT07048327
Recruiting
Phase 2
Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
Advanced Endometrial Cancer
3D Medicines (Sichuan) Co., Ltd.108 enrolled19 locationsNCT05112991
Recruiting
Not Applicable
PROfiling Based Endometrial Cancer Adjuvant Therapy
Endometrial Cancer Stage IEndometrial Cancer Stage II
Women's Hospital School Of Medicine Zhejiang University590 enrolled10 locationsNCT05179447
Recruiting
Phase 2
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
Ovarian CancerEndometrial CancerPrimary Peritoneal Cancer+1 more
Hansoh BioMedical R&D Company460 enrolled28 locationsNCT06014190